# SIPONIMOD
> **ANDA218444** · Abbreviated New Drug Application (Generic) · Sponsor: RICONPHARMA LLC · Approved 2025-04-22
## Drug
- **FDA Application Number:** ANDA218444
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SIPONIMOD
- **Generic name:** Siponimod
- **Active ingredients:** SIPONIMOD
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** RICONPHARMA LLC
- **First approval:** 2025-04-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218444)
---
*AI Analytics · CC0 1.0*